AEMD

$5.80+9.64%visit website

AETHLON MEDICAL INC

Market Cap

$4M

Live price × SEC shares (Aug 10, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.21

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.8

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q2 FY2026 Sep 30, 2025	Q3 FY2026 Dec 31, 2025	Q4 FY2026 Mar 31, 2026	Q1 FY2027 Jun 30, 2026	TTM Jun 30, 2026
Research & development	294	533	590	549	1,966
Total operating expenses	1,510	2,062	1,929	1,579	7,080
Operating income	(1,510)	(2,062)	(1,929)	(1,579)	(7,080)
Net income	(1,487)	(2,018)	(1,884)	(1,548)	(6,938)
EPS (basic) ($)	(3.74)	(2.45)		(4.02)	—
EPS (diluted) ($)	(3.74)	(2.45)		(4.02)	—
Weighted avg. shares (basic)	398	823		385
Weighted avg. shares (diluted)	398	823		385

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

18 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 9, 2026 accepted 8:15 PM ET	5.03Bylaws / fiscal year	Document SEC ↗
Oct 5, 2026 accepted 8:10 PM ET	8-K/A 5.07Shareholder vote	Document SEC ↗
Oct 1, 2026 accepted 9:24 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
Sep 17, 2026 accepted 12:03 PM ET	1.01Material agreement5.01Change in control7.01Reg FD disclosure	Document SEC ↗
Sep 15, 2026 accepted 12:17 PM ET	5.02Officer / director change	Document SEC ↗
Aug 31, 2026 accepted 1:15 PM ET	8.01Other events	Document SEC ↗
Aug 13, 2026 accepted 8:15 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jul 31, 2026 accepted 12:00 PM ET	3.03Holder rights modified5.03Bylaws / fiscal year	Document SEC ↗
Jul 8, 2026 accepted 11:07 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Jun 10, 2026 accepted 8:15 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

34%

W/W +17.8pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 2026-11-03

Aethlon Medical Stock Price Forecast. Should You Buy AEMD?

StockInvest.us · 2026-10-30

North Immunology joins biotech reverse merger boom with Aethlon deal

Yahoo Finance · 2026-09-17

Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis

Yahoo Finance · 2026-09-17

Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger

Yahoo Finance · 2026-09-17

AEMD Stock Soars 460% on the North Immunology Merger — But What Do Shareholders Actually Own?

TOP1markets · 2026-09-17

AEMD Stock Alert: Halper Sadeh LLC is Investigating Whether Aethlon Medical, Inc. is Obtaining a Fair Price for its Shareholders

Business Wire · 2026-09-17

A merger could put $180 million behind a new eczema treatment

Stock Titan · 2026-09-17

AEMD Stock Slides As Traders Brace For Q1 2026 Update

timothysykes.com · 2026-08-28

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program

Yahoo Finance · 2026-08-13

Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®

Yahoo Finance · 2026-07-13

Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

Yahoo Finance · 2026-07-06

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®

Yahoo Finance · 2026-06-26

Aethlon Medical advances Hemopurifier study as final trial cohort nears completion

Yahoo Finance · 2026-06-17

symbol__ Stock Quote Price and Forecast

CNN · 2024-03-26

Informational purposes only, not investment advice.

Corporate Events (8-K)

18 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 9, 2026 accepted 8:15 PM ET	5.03Bylaws / fiscal year	Document SEC ↗
Oct 5, 2026 accepted 8:10 PM ET	8-K/A 5.07Shareholder vote	Document SEC ↗
Oct 1, 2026 accepted 9:24 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
Sep 17, 2026 accepted 12:03 PM ET	1.01Material agreement5.01Change in control7.01Reg FD disclosure	Document SEC ↗
Sep 15, 2026 accepted 12:17 PM ET	5.02Officer / director change	Document SEC ↗
Aug 31, 2026 accepted 1:15 PM ET	8.01Other events	Document SEC ↗
Aug 13, 2026 accepted 8:15 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jul 31, 2026 accepted 12:00 PM ET	3.03Holder rights modified5.03Bylaws / fiscal year	Document SEC ↗
Jul 8, 2026 accepted 11:07 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Jun 10, 2026 accepted 8:15 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

AEMD

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

AETHLON MEDICAL INC (AEMD)

Factor Profile

Corporate Events (8-K)